Correlation Between Agilent Technologies and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agilent Technologies and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Agilent Technologies and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and NLS Pharmaceutics.
Diversification Opportunities for Agilent Technologies and NLS Pharmaceutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Agilent and NLS is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Agilent Technologies and NLS Pharmaceutics
Taking into account the 90-day investment horizon Agilent Technologies is expected to generate 2.01 times less return on investment than NLS Pharmaceutics. But when comparing it to its historical volatility, Agilent Technologies is 6.89 times less risky than NLS Pharmaceutics. It trades about 0.03 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 544.00 in NLS Pharmaceutics AG on September 3, 2024 and sell it today you would lose (206.00) from holding NLS Pharmaceutics AG or give up 37.87% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agilent Technologies vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Agilent Technologies |
| NLS Pharmaceutics |
Agilent Technologies and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agilent Technologies and NLS Pharmaceutics
The main advantage of trading using opposite Agilent Technologies and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.| Agilent Technologies vs. Danaher | Agilent Technologies vs. Guardant Health | Agilent Technologies vs. Charles River Laboratories |
| NLS Pharmaceutics vs. Neurobo Pharmaceuticals | NLS Pharmaceutics vs. Indaptus Therapeutics | NLS Pharmaceutics vs. Pasithea Therapeutics Corp | NLS Pharmaceutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |